U.S. FDA greenlights supply of Janssen vaccine to bolster fight against COVID-19

US – The U.S Food and Drug Administration (FDA) has under the emergency authorization use (EUA), authorized the production of the Janssen (Johnson & Johnson) COVID-19 Vaccine for use in the United States. According to a statement from the FDA, the approval will allow the manufacture of two batches of the Vaccine by the Emergent BioSolutions, a facility in Baltimore. The move comes at a time when US president Joseph Biden and his Vice Kamala Harris are stepping up the fight against corona virus with clarion calls for more citizens…

Read More

Aspen Pharmacare reacts to FDAs directive for a batch of Johnson & Johnson COVID-19 vaccines to be destroyed

SOUTH AFRICA – Aspen, a global multinational specialty pharmaceutical company, has sqaid in a statement released to the press that they are disappointed to learn specific batches of the Johnson & Johnson COVID-19 vaccine manufactured at  Gqeberha production site and designated for the South African market have to be destroyed due to the Good Manufacturing Practice risk of isolated material in the drug substance supplied to Aspen by Johnson & Johnson from their contract manufacturing partner in the USA, Emergent.  The batches manufactured had been retained in storage awaiting the…

Read More

South Africa rolls back on FDA unwholesome-termed Johnson&Johnson COVID vaccines

SOUTH AFRICA – The South African Health Products Regulatory Authority (SAHPRA) has announced it will not release Johnson& Johnson(J&J) vaccines produced using the drug substance batches that were not suitable. South Africa, which is struggling to roll out its inoculation program as it enters a third wave of the pandemic, said it will pull two million of doses of the Johnson & Johnson vaccine following contamination concerns at one of the US drug maker’s sites. This follows an announcement made by the US Food and Drug Administration that millions of…

Read More

J&J inks deal with African Vaccine Acquisition Trust for its COVID-19 vaccine candidate

AFRICA – Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate to African Union’s 55 member states with delivery beginning in the third quarter of 2021. AVAT also has the potential to order an additional 180 million doses, for a combined total of up to 400 million doses through 2022. The availability of the vaccine candidate is subject to its successful…

Read More

Healthtech startup Redbird secures US$1.5m investment for expansion to new market

GHANA – Redbird, an Accra-based healthtech startup, has secured US$1.5 million in a Seed Round of investment with participation from Johnson & Johnson Foundation and Newtown Partners via the Imperial Venture Fund. According to the startup, the funding will be used to expand Redbird’s business model, operations and to enter new markets. “We’re thrilled to work with Johnson & Johnson Impact Ventures and Newtown Partners. Newtown and Imperial’s expertise in African supply chains, coupled with Johnson & Johnson’s long-standing commitment to improving care for the most vulnerable populations through technology, create…

Read More